U.S. DEA Moves to Restrict Hydrocodone-Combination Prescriptions (TEVA) (MNK) (ABBV)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Mallinckrodt plc (MNK) Promotes SVP Phillips to Autoimmune and Rare Diseases President
August 22, 2014 9:10 AM EDTMallinckrodt plc (NYSE: MNK) announced that Gary Phillips, MD, current Senior Vice President and Chief Strategy Officer, has been appointed to serve as Senior Vice President and President of the Companys Autoimmune and Rare Disease business, which includes the commercial organization supporting H.P. Acthar® Gel. Additionally, Ray Furey, formerly Senior Vice President and Chief Compliance Officer at Questcor Pharmaceuticals, has been appointed as Senior Vice President and the Chief Compliance Officer at Mallinckrodt. The appointments are effective immediately.
In his new role, Dr. Phillips will assume responsibility for the Acthar... More
